Associated Papers
Molecular dynamics of select missense mutations of Apolipoprotein E and their implications in Hyperlipoproteinemia type III.
Thakur S et al.
Biochemistry and Biophysics Reports, 2025
Impact of Apolipoprotein E Variants: A Review of Naturally Occurring Variants and Clinical Features.
Matsunaga A et al.
Journal of Atherosclerosis and Thrombosis, 2025
Corrigendum to "APOE gene variants in primary dyslipidemia" [Atherosclerosis (2021 Jul) 328 11-22].
Abou Khalil Y et al.
Atherosclerosis, 2023
Genetics of Alzheimer's disease: an East Asian perspective.
Miyashita A et al.
Journal of Human Genetics, 2023
Establishing the relationship between familial dysbetalipoproteinemia and genetic variants in the APOE gene.
Heidemann BE et al.
Clinical Genetics, 2022
35781703 (PubMed )
Supplement: CGE-102-253-s001.docx
Systematic analysis of the intersection of disease mutations with protein modifications.
Simpson CM et al.
Bmc Medical Genomics, 2019
31345222 (PubMed )
Supplement: 12920_2019_543_MOESM6_ESM.xlsx › S5C
Apolipoprotein E in lipoprotein metabolism, health and cardiovascular disease.
Marais AD
Pathology, 2019
Hyperlipoproteinemia type 3: the forgotten phenotype.
Hopkins PN et al.
Current Atherosclerosis Reports, 2014
Apolipoprotein E mutations: a comparison between lipoprotein glomerulopathy and type III hyperlipoproteinemia.
Matsunaga A et al.
Clinical and Experimental Nephrology, 2014
APOE1 mutation in a patient with type III hyperlipoproteinaemia: detailed genetic analysis required.
Visser ME et al.
The Netherlands Journal of Medicine, 2012
Select a paper to view details